ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2666

Causes of Stillbirths in Women with SLE

Evelyne Vinet1, Geneviève Genest2, Susan Scott2, Christian A. Pineau3, Ann E. Clarke4, Robert W. Platt5 and Sasha Bernatsky6, 1McGill University Health Center, Montreal, QC, Canada, 2McGill University Health Centre, Montreal, QC, Canada, 3Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 4Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 5McGill University, Montreal, QC, Canada, 6Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: pregnancy and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose

It is believed that pregnant women with SLE face an increased risk of stillbirths, although there are few precise or recent estimates of the magnitude of the effect. As well, no one to date has investigated the causes of stillbirths in SLE pregnancy. Using the “Offspring of Systemic Lupus Erythematous Registry (OSLER)”, we examined stillbirths and the cause of their death in SLE mothers versus those without SLE.

Methods:

OSLER is a large population-based cohort, which includes all women who had one or more hospitalizations for delivery after SLE diagnosis, identified through Quebec’s healthcare databases (1989-2009). OSLER also includes a randomly selected control group of healthy women, matched at least 4:1 for age and year of delivery. We identified stillbirths (defined as intrauterine deaths occurring at or after 20 weeks of gestational age) from SLE mothers and their matched controls and ascertained the cause of death as indicated on the death certificate. We performed a multivariate logistic regression analysis, using generalized estimating equations, to estimate the risk of stillbirths in SLE offspring versus controls, adjusting for maternal education, comorbidities (i.e. hypertension, diabetes, asthma, depression), and multiple births.

Results:

509 women with SLE had 729 births, including 9 stillbirths (1.4%), while 5829 matched controls had 8541 births including 47 stillbirths (0.6%). Compared to controls, women with SLE had an increased risk of having a stillbirth (adjusted OR 2.16, 95% CI 1.05, 4.44). Among women having a stillbirth, median maternal age was identical for both SLE and control mothers [respectively 31.0 years (IQR 29.0, 32.0) and 31.0 years (IQR 26.5, 30.5)]. There was a trend for more female stillbirths born to women with SLE (6 of nine stillbirths were female) compared to controls (22/47) (OR 2.27, 95% CI 0.54, 9.41). In addition, stillbirths in SLE mothers occurred at a younger median gestational age compared to controls [29 weeks (IQR 28, 31) versus 35 weeks (IQR 27, 38)].

Causes of death in SLE and control stillbirths are illustrated in Table 1. We observed a trend for higher risk in SLE mothers versus controls for stillbirths due to maternal hypertensive disorders and placental abruption [respectively OR 6.43 (95% CI 0.8, 53.3) and OR 4.19 (95% CI 0.59, 29.72)].

Conclusion:

Compared to women from the general population, women with SLE appear to have an increased risk of stillbirths, although it must be emphasized that most pregnancies in SLE are not complicated by this event. Stillbirths in mothers with SLE might be more often caused by maternal hypertensive disorders and placental abruption compared to stillbirths in mothers without SLE.

Table 1. Causes of death among SLE and control stillbirths

Causesa

SLE stillbirths

(n=9)

Control stillbirths

(n=47)

Hypertensive disorders, n (%)

2 (22)

2 (4)

Placental abruption, n (%)

2 (22)

3 (6)

Placental disorders, n (%)

0 (0)

3 (6)

Congenital abnormality, n (%)

1 (11)

3 (6)

Umbilical cord abnormality, n (%)

              1 (11)

3 (6)

Obstetrical complications, n (%)

1 (11)

21 (45)

Maternal medical condition, n (%)

0 (0)

1 (2)

Infection, n (%)

1 (11)

1 (2)

Other, n (%)

1 (11)

3 (6)

Unknown n, (%)

0 (0)

7 (15)

aReference for classification of causes of death: Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA. 2011 Dec 14;306(22):2459-68.


Disclosure:

E. Vinet,
None;

G. Genest,
None;

S. Scott,
None;

C. A. Pineau,
None;

A. E. Clarke,
None;

R. W. Platt,
None;

S. Bernatsky,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/causes-of-stillbirths-in-women-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology